Financings Roundup
Kythera, Intercept Dazzle with Dueling Initial Public Offerings
Intercept Pharmaceuticals Inc. and Kythera Biopharmaceuticals Inc. each priced initial public offerings (IPO) at the top of their ranges Thursday, and both companies' stock surged, selling several dollars above even that top price.